Filter posts

Session Recap: Advances in Ophthalmology: Therapies for Saving Sight

Monday at the BIO CEO & Investor Conference featured a 9:30am panel that offered a …

Announcing the BIO/Bloomberg Intelligence: 2016 Biotech Industry Outlook Survey

BIO, in conjunction with Bloomberg Intelligence, invites you to answer a brief, 3-minute, industry outlook …

Vote for the Buzz of BIO at the 2016 BIO CEO & Investor Conference

Voting is now open! See the 20 nominees and cast your vote once per day …

Be the Buzz of BIO at the 2016 BIO CEO and Investor Conference

The nomination period is underway for the Buzz of BIO content at the 2016 CEO …

The Perfect Close

With a fast and furious finish, yesterday, March 2nd, the Nasdaq Composite (IXIC) closed at …

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

The 17th Annual BIO CEO & Investor Conference, the largest investor conference focused on established …

FOX Business: BIO CEO Jim Greenwood Discusses Future of Medicine

BIO President and CEO Jim Greenwood appeared on Fox Business during the 17th Annual BIO …

Nasdaq Social Bell: Twitter Strategies For Biotechs

Last week at the BIO CEO & Investor Conference in New York City, I had …

Deal Structures: More Options for Companies

By most measures, 2014 was a great year for the biotechnology industry. Venture capital deal …

Fireside Chats with Five CEOs Featured at Day Two of the BIO CEO & Investor Conference

Fireside Chat with John F. Milligan, PhD, President & COO, Gilead Sciences The first fireside …